Exhibit 99.1

News Release

For Further Information:

Laura Robinette 310-444-4300

For Immediate Release

Catasys Reports 2017 Third Quarter Financial Results

Los Angeles, CA — November 14^th, 2017— Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today reported its financial results for the third quarter and nine months ended September 30, 2017. The Company provides big data based analytics and predictive modeling driven behavioral healthcare services to health plans and their members through its OnTrak™ solution.

Third Quarter 2017 and Recent Business Highlights

2018 Guidance

Management Commentary

Mr. Rick Anderson, President and COO of Catasys, stated, “We saw a significant increase in the size of our eligible lives outreach totals in the third quarter of 2017, which we believe will lead to a significant ramp up in enrollment in the coming months.  Outreach totals increased to 25,000 individuals during the quarter, which is the highest in Catasys’ history, and our enrollment has increased by 40% from the end of the second quarter.  Over the past few months, we have seen enrollment increasing across our book of business and customer relationships.  In the third quarter, for one customer, we expanded OnTrak for the treatment of substance use disorder (SUD) into an additional state and also expanded the treatment of anxiety to 3 states.  In addition, we launched enrollment with one of the nation’s largest health plans in Oklahoma for the treatment of SUD, depression and anxiety. We expect to see continued enrollment growth in the fourth quarter and beyond. In fact, October’s billings of $1.1 million were our largest to date. While enrollment increased during the third quarter, billings were impacted as our largest customer requires us to bill our fees over a limited number of visits to our network providers rather than upon enrollment.  This results in a mis-match between billings and enrollment, and differs from our billing practices with our other customers.  We anticipate this to be a timing element and expect it to be remedied in future quarters.”

Outlook for 2018

Mr. Terren Peizer, Chairman and CEO of Catasys, stated, “Based solely on the higher number of outreach totals during the third quarter and the associated enrollment ramp up, we project $20.0 million in billings for 2018. In past quarters, Catasys has been reluctant to provide this guidance, largely due to the wide range of variability for timing in customer launch dates. However, due to our current outreach pool of 25,000 and our typical ramp up timeline for enrollment, we feel very confident that this guidance will serve as a conservative floor for the coming year based solely on our current outreach pool and launched programs. Over the coming months we hope to further expand our outreach pool via the addition of new health plan customer contracts, the launching of our OnTrak program in previously announced contracts, and expansions within contracts currently launched. All of these revenue drivers provide upside potential for Catasys’ expected revenue totals for the coming year.”

Third Quarter and Nine Month Financial and Operating Review

Billings 

Revenues

Deferred Revenue

Operating Expenses

Net Income (Loss)

Conference Call – November 14, 2017 – 4:30 PM ET

The Company will also host a conference call/webcast at 4:30 pm ET/1:30 pm PT.

Investors, analysts, employees and the general public are invited to listen to the conference call via:

Conference Call:     877-705-2969 (domestic) or 201-689-8868 (international)

Webcast:          http://catasys.equisolvewebcast.com/q3-2017

Those who are unable to attend the conference call live can use the following information to hear a replay version:

Conference ID#: 13672721

Conference Call Replay: 877-660-6853 (domestic) or 201-612-7415 (international)

Expiration Date: 11/21/2017

About Catasys, Inc.

Catasys, Inc. provides big data based analytics and predictive modeling driven behavioral healthcare services to health plans and their members through its OnTrak solution. Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to improve member health and, at the same time, lower costs to the insurer for underserved populations where behavioral health conditions cause or exacerbate co-existing medical conditions. The solution utilizes proprietary analytics and proprietary enrollment, engagement and behavioral modification capabilities to assist members who otherwise do not seek care through a patient-centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient treatment solution.

OnTrak is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is currently available to members of several leading health plans in Connecticut, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Non-GAAP Financial Measures

The Company makes reference in this press release to billings, non-GAAP financial measures, as supplemental measures to review and assess our operating performance. The presentation of this non-GAAP financial measure is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with US GAAP. We define billings as the amount invoiced in a particular period pursuant to existing contracts based on enrolled members. We use billings as measures of operating performance to assist in comparing performance from period to period on a consistent basis.

We believe that the use of these non-GAAP financial measures facilitates investors’ assessment of our operating performance from period to period and from company to company by backing out potential differences caused by variations in the applicable performance requirements contained in the relevant contracts, which may be different from other companies in our industry.

Billings are not defined under GAAP and is not presented in accordance with GAAP. These non-GAAP financial measures have limitations as an analytical tool, and when assessing our operating performance, investors should not consider them in isolation, or as a substitute for revenue prepared in accordance with GAAP. A reconciliation from these non-GAAP financial measures to the GAAP financial measures is included at the end of this release.